Innovation & intellectual property · 06/01/2015Updated: 10/17/2026 · 1 min read
U.S. Patent Office Grants Interim Extension for INTERCEPT Blood System
Summary
The U.S. Patent and Trademark Office has issued a one-year extension for the term of U.S. Patent No. 5,593,823, which covers the INTERCEPT Blood System for Plasma, due to a second interim extension under the patent term adjustment provisions.
Original source language: Federal Register — Patent and Trademark OfficeOpen original release →